SerenaGroup® is recognized internationally for being at the forefront of wound healing research. Our large patient volume affords us the ability to conduct clinical trials for major pharmaceutical and device companies. Our research provides novel treatment to patients with chronic non-healing wounds.
We have conducted over 100 clinical trials on growth factors, gene therapy, bioengineered skin products and novel pharmaceuticals. Our research efforts have produced over 130 abstracts, 100 manuscripts and 900 presentations worldwide. We have shared our expertise across the globe, having treated patients in Cambodia, in Haiti following the earthquakes, Vietnam, and in Rwanda conducting clinical trials on the Prevention of HIV.
A word from our Research Director:
“Our research team strives to provide the highest quality research outcomes in the most timely and efficient manner possible. We value all of our clients (from our sponsors to our research subjects) and treat them with the utmost dignity and respect.”
Sharon McConnell, MS CCRC, Director of Research